Enrolling: Bateman-Horne InTime Drug Intervention Trial

The InTime Trial aims to assess the effects of the investigational drug, CT38, in terms of its safety and effectiveness in treating ME/CFS. There will be 18 people between 18 and 60 years of age enrolled in this study and participation will last up to approximately 4 months.
Who:
Dr. Lucinda Bateman, Located in Salt Lake City, Utah at the Bateman-Horne Institute.

When:

Ongoing


What:

A Clinical Trial for ME/CFS Patients: BHC is conducting a small interventional trial, to test the effectiveness of a new drug that may improve functioning and/or reduce the symptoms in ME/CFS patients. The drug has been shown to be safe in a Phase 1 trial in healthy humans.


Where:

Bateman-Horne Institute, Salt Lake City, Utah


How to Participate:

If you are interested in participating in this trial, please follow the link below and fill out the following form to check for eligibility:
https://redcap01.brisc.utah.edu/ccts/redcap/surveys/?s=MC4EAT4YNE

Facebook
Twitter
WhatsApp
Email

Latest News

red rectangle with a background filled with layered red hearts. The MEAction logo and the Nourish Therapeutic Yoga logo at the top. The words Modified Movement Class in white script font. Below that in white lettering, friday, february 14th at 11am 2pm7pm

A Heart-filled Very Modified Movement Class on 2/14

♥️ Join #MEAction for a heart-filled, very modified movement class of the year on Friday, February 14th at 11am PST/2pm EST/7pm GMT. ♥️This class has been crafted specifically for people with ME. This 30 minute class will be hosted virtually. We are thrilled to partner with Shannon Williams-Bramburger of Nourish Therapeutic Yoga, who has been

Read More »
Scroll to Top